The purpose of this study is to evaluate the safety, tolerability and effectiveness of FLX-787-ODTto treat muscle cramps in motor neuron disease.
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study NCT 03196375.
Subjects with motor neuron disease including amyotrophic lateral sclerosis (ALS), primary lateral sclerosis(PLS), or progressive muscular atrophy (PMA), who have at least 3 "Charlie horse" type muscle cramps per week.
June 01, 2018